VIGIL - Use of PCR-Sars-CoV-2 in Children (VIGIL)
Head :
JUNG Camille
Last update : 02/23/2021 | Version : 1 | ID : 73890
| General | |
| Identification | |
| Detailed name | Use of PCR-Sars-CoV-2 in Children (VIGIL) |
| Sign or acronym | VIGIL |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | NCT04412317 |
| General Aspects | |
| Medical area |
Maladies infectieuses |
| Study in connection with Covid-19 |
Oui |
| Scientific investigator(s) (Contact) | |
| Name of the director | JUNG |
| Surname | Camille |
| camille.jung@chicreteil.fr | |
| Collaborations | |
| Participation in projects, networks and consortia |
Oui |
| Details | ACTIV-Association Clinique et thérapeutique infantile du val de marne |
| Funding | |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CHI Créteil |
| Organisation status |
Public |
| Presence of scientific or steering committees |
Oui |
| Additional contact | |
| Name of the contact | LEVY |
| Surname | Corinne |
| corinne.levy@activ-france.fr | |
| Organization | ACTIV |
| Main features | |
| Type of database | |
| Type of database |
Bases de données issues d’enquêtes |
| Study databases (details) |
Etudes de cohortes |
| Database recruitment is carried out by an intermediary |
Via une sélection de professionnels d'exercice libéral |
| Database recruitment is carried out as part of an interventional study |
Non |
| Database objective | |
| Main objective | Pourcentage de patients positifs pour le covid-19 |
| Inclusion criteria |
Enfants <15 ans
indication à une PCR ou un test antigénique rapide Covid19 |
| Population type | |
| Age |
Nouveau-nés (naissance à 28j) Nourrissons (28j à 2 ans) Petite enfance (2 à 5 ans) Enfance (6 à 13 ans) Adolescence (13 à 18 ans) |
| Population covered |
Population générale |
| Pathology | |
| Gender |
Masculin Féminin |
| Geography area |
National |
| Data collection | |
| Dates | |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individus |
| Data | |
| Database activity |
Collecte des données active |
| Type of data collected |
Données cliniques Données paracliniques |
| Presence of a biobank |
Non |
| Procedures | |
| Followed pathology | |
| Promotion and access | |
| Promotion | |
| Access |
